These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6985931)

  • 1. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
    Benson MD; Kleiner E
    J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural evidence for the synthesis of serum amyloid A protein by murine hepatocytes.
    Takahashi M; Yokota T; Yamashita Y; Ishihara T; Uchino F
    Lab Invest; 1985 Feb; 52(2):220-3. PubMed ID: 3881624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection.
    Miura K; Takahashi Y; Shirasawa H
    Lab Invest; 1985 Oct; 53(4):453-63. PubMed ID: 3900582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response.
    Brandwein SR; Sipe JD; Tatsuta E; Skinner M; Cohen AS
    J Rheumatol; 1984 Oct; 11(5):597-601. PubMed ID: 6334740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.
    Kisilevsky R; Boudreau L; Foster D
    Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synthesis of the acute phase reactant SAA by hepatocytes.
    Benson MD
    Ann N Y Acad Sci; 1982; 389():116-20. PubMed ID: 6953914
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition.
    Kisilevsky R; Benson MD; Axelrad MA; Boudreau L
    Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes.
    Baltz ML; Dyck RF; Pepys MB
    Immunology; 1980 Sep; 41(1):59-66. PubMed ID: 7000694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures.
    Tatsuta E; Sipe JD; Shirahama T; Skinner M; Cohen AS
    Arthritis Rheum; 1984 Mar; 27(3):349-52. PubMed ID: 6704197
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous participation of the hepatocyte population in amyloid protein AA synthesis.
    Shirahama T; Skinner M; Cohen AS
    Cell Biol Int Rep; 1984 Oct; 8(10):849-56. PubMed ID: 6509560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical study of hepatocyte synthesis of amyloid AA. Demonstration of usual site of synthesis and intracellular pathways but unusual retention on the surface membrane.
    Shirahama T; Cohen AS
    Am J Pathol; 1985 Jan; 118(1):108-15. PubMed ID: 3881036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response.
    Vreugdenhil AC; Dentener MA; Snoek AM; Greve JW; Buurman WA
    J Immunol; 1999 Sep; 163(5):2792-8. PubMed ID: 10453023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monokine-induced synthesis of serum amyloid A protein by hepatocytes.
    Selinger MJ; McAdam KP; Kaplan MM; Sipe JD; Vogel SN; Rosenstreich DL
    Nature; 1980 Jun; 285(5765):498-500. PubMed ID: 7402294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental amyloidosis. Role of the hepatocytes and Kupffer cells in amyloid formation.
    Uchino F; Takahashi M; Yokota T; Ishihara T
    Appl Pathol; 1985; 3(1-2):78-87. PubMed ID: 3915947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.
    Kisilevsky R; Boudreau L
    Lab Invest; 1983 Jan; 48(1):53-9. PubMed ID: 6823091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-enhancing factor mediates amyloid formation on fibroblasts via a nidus/template mechanism.
    Magy N; Liepnieks JJ; Benson MD; Kluve-Beckerman B
    Arthritis Rheum; 2003 May; 48(5):1430-7. PubMed ID: 12746917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine inhibition of the first phase of amyloid synthesis in experimental animals.
    Keizman IK; Greenwald M; Ravid M
    Br J Exp Pathol; 1976 Dec; 57(6):686-8. PubMed ID: 1008998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin.
    Yamada T; Liepnieks J; Benson MD; Kluve-Beckerman B
    J Immunol; 1996 Jul; 157(2):901-7. PubMed ID: 8752944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic demonstration of cytoplasmic ASSAM-related antigenic substance (CASSAM) by an immunoperoxidase technique.
    Takeshita S; Higuchi K; Hosokawa M; Matsumura A; Higuchi K; Kohno A; Matsushita M; Yonezu T; Takeda T
    Am J Pathol; 1985 Dec; 121(3):455-65. PubMed ID: 3907365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.